(Q38871708)

7 September 2017

title

Frequency of red cell alloimmunization in patients with sickle cell anemia in an Egyptian referral hospital (English)

1 reference

7 September 2017

0 references

Rabab Aly

1

1 reference

7 September 2017

Mohamed R El-sharnoby

series ordinal

2

1 reference

7 September 2017

Adel A Hagag

series ordinal

3

1 reference

7 September 2017

publication date

13 September 2012

1 reference

Transfusion and Apheresis Science

7 September 2017

published in

1 reference

7 September 2017

volume

47

1 reference

7 September 2017

issue

3

1 reference

7 September 2017

page(s)

253-257

1 reference

The role of molecular immunohematology in sickle cell disease

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Red blood cell alloimmunization in sickle cell disease patients in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Current issues in blood transfusion for sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy--a review of cases from 1997 to 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Blood group antibodies and their significance in transfusion medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Current issues with blood transfusions in sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Allosensitization in patients receiving multiple blood transfusions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Antigen-matched donor blood in the transfusion management of patients with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

[Transfusion and alloimmunization in sickle cell anemia patients]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

The incidence of development of irregular red cell antibodies in patients with sickle cell anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

RBC alloimmunization and autoimmunization among transfusion‐dependent Arab thalassemia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Red cell alloantibodies in patients with thalassemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Thalassemia intermedia: revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Post-transfusion alloimmunization in patients with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Alloantibody responses in multiply transfused sickle cell patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Should chronic transfusions be matched for antigens other than ABO and Rho(D)?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

Risk factors for alloimmunization by patients with sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2012.07.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRANSCI.2012.07.014

1 reference

7 September 2017

1 reference